Your browser doesn't support javascript.
loading
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.
Wedzicha, Jadwiga A; Zhong, Nanshan; Ichinose, Masakazu; Humphries, Michael; Fogel, Robert; Thach, Chau; Patalano, Francesco; Banerji, Donald.
Afiliação
  • Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, UK.
  • Zhong N; State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
  • Ichinose M; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Humphries M; Beijing Novartis Pharma Co. Ltd., Shanghai, People's Republic of China.
  • Fogel R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Thach C; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Patalano F; Novartis Pharma AG, Basel, Switzerland.
  • Banerji D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Article em En | MEDLINE | ID: mdl-28176893

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Broncodilatadores / Quinolonas / Antagonistas Muscarínicos / Doença Pulmonar Obstrutiva Crônica / Povo Asiático / Agonistas de Receptores Adrenérgicos beta 2 / Combinação Fluticasona-Salmeterol / Glicopirrolato / Indanos / Pulmão Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Broncodilatadores / Quinolonas / Antagonistas Muscarínicos / Doença Pulmonar Obstrutiva Crônica / Povo Asiático / Agonistas de Receptores Adrenérgicos beta 2 / Combinação Fluticasona-Salmeterol / Glicopirrolato / Indanos / Pulmão Idioma: En Ano de publicação: 2017 Tipo de documento: Article